论文信息 - Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial - 字舞流文

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

B. Gazzard | D. Cooper | P. Phanuphak | S. Emery | J. Amin | R. Puls | C. Orrell | B. Young | A. Hill | M. Losso | M. Wolff | T. Read | E. Shahar | C. Nwizu | Chidi A. Nwizu